Showing results (1311-1320 of 2,905) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|November 24, 2018
Arming oncolytic reovirus with GM-CSF gene to enhance immunityVera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, et al.Cancer Gene Therapy|October 22, 2016
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomyH Kumon, Y Ariyoshi, K Sasaki, et al.Cancer Gene Therapy|October 22, 2016
Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome themS Sengupta, G Mao, Z S Gokaslan, et al.Cancer Gene Therapy|January 14, 2017
Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunityC Sakamoto, H Kohara, H Inoue, et al.Cancer Gene Therapy|January 14, 2017
Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancerX Yan, S-C Jiao, G-Q Zhang, et al.Cancer Gene Therapy|April 22, 2017
Preclinical study of rAAV2-sTRAIL: pharmaceutical efficacy, biodistribution and safety in animalsQ Ru, W Li, X Wang, et al.Cancer Gene Therapy|March 29, 2008
Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapyM Guan, V Tripathi, X Zhou, et al.Cancer Gene Therapy|January 1, 1997
Efficiency of retroviral transduction into hematopoietic cells by cocultivation procedure does not correlate with viral titerC Bagnis, C Chischportich, A M Imbert, et al.Cancer Gene Therapy|January 1, 1997
Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude miceY Sugimoto, S Sato, S Tsukahara, et al.Cancer Gene Therapy|November 1, 1996
Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cellsM Kaji, Y Yonemura, S Harada, et al.Pageof 291